Search

Your search keyword '"Shea, Lauren"' showing total 218 results

Search Constraints

Start Over You searched for: Author "Shea, Lauren" Remove constraint Author: "Shea, Lauren"
218 results on '"Shea, Lauren"'

Search Results

1. Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study

3. Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

7. Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study

8. Science Plus ELA: A Natural Fit

9. Comparison of Student Success between High-Clicker and Low-Clicker Frequency in a Large-Enrollment Introductory Biology Course

10. Examining the Extremes: High and Low Performance on a Teaching Performance Assessment for Licensure

11. Classroom Practices That Support the Development of Purpose

15. We Are All Talking: A Whole-School Approach to Professional Development for Teachers of English Learners

18. Exploring the Influences of a Partner-Based Teacher Credential Program on Candidates’ Performance Outcomes

19. 74. Genomic analyses of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common clonal origin

21. Postibrutinib Relapse Outcomes for Patients with Marginal Zone Lymphoma

23. Interim Analysis of Investigator-Initiated Phase 2 Trial of Siltuximab in Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR T-Cell Therapy

24. Postibrutinib relapse outcomes for patients with marginal zone lymphoma

25. Additional file 1 of Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study

26. Myosteatosis As a Predictor of Toxicity Among Older Adults with DLBCL Receiving CHOP-Based Regimens

28. Impact of Monoclonal Protein at Diagnosis on Outcomes in Patients with Marginal Zone Lymphoma: A Multicenter Cohort Study

29. Early Relapse within 24 Months after Frontline Systemic Therapy (POD24) Is Associated with Worse Survival in Patients with Marginal Zone Lymphoma: A US Multisite Study

30. Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy

33. Incorporating English Language Teaching through Science for K-2 Teachers

34. Predicting Performance: A Comparison of University Supervisors' Predictions and Teacher Candidates' Scores on a Teaching Performance Assessment

35. Talking to Learn: A Mixed-Methods Study of a Professional Development Program for Teachers of English Language Learners

36. Methods and Strategies: Talk Strategies

37. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

38. Chimeric Antigen Receptor T Cells Mediated Toxicities Are Associated with Hyponatremia

40. Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

41. Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers

42. Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

43. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

44. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease

47. Predictive Factors and Outcomes for Ibrutinib Therapy in Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter Cohort Study

49. Association of trainee participation with adenoma and polyp detection rates

Catalog

Books, media, physical & digital resources